Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.35 USD | +2.57% | +6.38% | -29.72% |
May. 16 | Advanced Oxygen Therapy plans London float - Sky News | AN |
May. 15 | Walgreens to Sell Over-the-Counter Naloxone Anti-Narcotic Spray to Reverse Opioid Overdoses | MT |
Financials (USD)
Sales 2024 * | 145B | Sales 2025 * | 151B | Capitalization | 15.43B |
---|---|---|---|---|---|
Net income 2024 * | -7.16B | Net income 2025 * | 1.82B | EV / Sales 2024 * | 0.16 x |
Net Debt 2024 * | 7.17B | Net Debt 2025 * | 6.78B | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
-2.2
x | P/E ratio 2025 * |
9.27
x | Employees | 268,500 |
Yield 2024 * |
7.33% | Yield 2025 * |
5.65% | Free-Float | 60.8% |
Latest transcript on Walgreens Boots Alliance, Inc.
1 day | +2.57% | ||
1 week | +6.50% | ||
Current month | +3.50% | ||
1 month | +3.97% | ||
3 months | -17.68% | ||
6 months | -14.85% | ||
Current year | -29.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 23-10-22 | |
Manmohan Mahajan
DFI | Director of Finance/CFO | 45 | 16-01-31 |
Stefano Pessina
CHM | Chairman | 83 | 12-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Hanson
BRD | Director/Board Member | 57 | 22-10-26 |
Valerie Jarrett
BRD | Director/Board Member | 67 | 20-10-28 |
Ginger Graham
BRD | Director/Board Member | 68 | 10-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 18.34 | +2.52% | 7,253,415 |
24-05-15 | 17.89 | -2.51% | 7,951,140 |
24-05-14 | 18.35 | +1.27% | 10,081,909 |
24-05-13 | 18.12 | +5.41% | 17,992,970 |
24-05-10 | 17.19 | -0.35% | 8,742,861 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.72% | 15.43B | |
-20.84% | 12.31B | |
-24.53% | 6.59B | |
+12.34% | 6.3B | |
-8.87% | 5.88B | |
-1.17% | 4.74B | |
+60.03% | 4.7B | |
-5.50% | 4.03B | |
-8.59% | 3.58B | |
-7.32% | 3.07B |
- Stock Market
- Equities
- WBA Stock